11 Salt Creek LaneHinsdale, IL 60521Phone: 847-391-9777Fax: 630-972-6259www.ilacc.org | www.wcacc.org

Friday, May 29, 20157:00 am - 4:15 pm

The Hyatt Lodge at McDonald’s Campus2815 Jorie Boulevard

Oak Brook, Illinois 60523

Hot topics in contemporary cardiovascular

practice &

il-acc annual meeting

Illinois ChapterWisconsin Chapter

Joint Providership/Co-provided by the ACC Foundation:

In Cooperation With:

Program Director: Firas Al Badarin, MD, FACCPrairie Cardiovascular ConsultantsHeart Institute of Southern Illinois

Content Representative: Cathie Biga, RN, MSN, President and CEO, Cardiovascular Management of Illinois

Nurse Planner: Nathalie DeMichelis, RN, BSNCV Program ManagerUC Irvine Healthcare California

COURSE GOAL & STATEMENT OF NEED

The rapidly changing healthcare environment often leaves the entire CV team struggling to find the most current and up to date information to manage their patients and practices. From new treatment guidelines to the multiple regulatory requirements, this educational conference will provide the CV team an opportunity to identify the most current available information for the clinical and business side of cardiology.

The overall goal of this activity is to improve patient care by increasing learner competence in understanding the newest treatments and guidelines in major cardiovascular diseases and understanding where healthcare is headed from the business side of cardiology.

ACCREDITATION & DESIGNATION STATEMENT

CME/Physician: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Cardiology Foundation (ACCF) and the Illinois Chapter of the American College of Cardiology. The ACCF is accredited by the ACCME to provide continuing medical education for physicians. The ACCF designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

CNE/Nursing: The American College of Cardiology Foundation (ACCF) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

The ACCF designates this educational activity for a maximum of 6.25 continuing education hours. Requirements for successful completion are attendance in a session in its entirety and completing the evaluation tool.

While offering credits as noted above, this program is not intended to provide extensive training or certification in the field.

TARGET AUDIENCE

This meeting is designed for Cardiologists, Cardiology Administrators, Nurses, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, Pharmacists and any other interested specialties.

LEARNER OBJECTIVES

Upon completion of this program, attendees should be able to:• Define the proper duration of dual anti-

platelet therapy following drug-eluting stents.

• Evaluate risks and benefits of using DAPT in combination with target-specific oral anticoagulants.

• Identify challenges and opportunities for success when establishing a new structural heart program.

• Recognize the role of novel structural cardiac interventions in contemporary practice.

• Define the current indications and appropriate patients who may benefit for TAVR and MitraClip.

• Identify the importance of team based care in the evolving cardiovascular delivery system.

• Recognize the epidemiology, and long term outcomes for adults with congenital heart disease.

• Identify solutions to improve the quality of care for ACHD patients in 2015 and over the next decade.

• Identify one aspect of each of the four main quality programs in the hospital setting (i.e. 30-day readmissions, hospital acquired conditions, core measures, and 30-day mortality rates).

• Identify one aspect of each of the three main quality programs, (i.e. VBP, MU, and PQRS) that has an impact in the ambulatory practice setting.

• Identify the roles and responsibilities that are necessary for a flexible, dynamic, clinically and financially successful team based model.

• Identify four key elements that are critical to a successful CV Service Line.

• Identify what are the key pillars the College has formed to facilitate the dissemination of clinical guidelines and the improvement of critical practice guidelines to the care delivery team.

OverviewOverview

CME/CNE Credit and EvaluationThe American College of Cardiology Foundation will e-mail each participant in this CME/CNE activity an online evaluation to be completed before issuing the CME/CNE Certificate. Add Assessment@acc.org to your “Trusted Sender” list to make sure you receive the evaluation notice. Please contact the chapter office if you do not receive an e-mail by June 8.

Ginger Biesbrock, PA-C, MPH, MPAS, AACCVice President, Consulting, MedaxiomNothing to Disclose

Cathie Biga, RN, MSN, President & CEOCardiovascular Management of IllinoisIL-ACC Administrator RepresentativeOwnership Interest/Partnership/Principal: CMI, Aftershock; Speaker’s Bureau: MedAxiom Advisory BoardConsulting Fees, Honoraria: Cardiology Advocacy Committee

Steve Brewer, MBA, CMPE, FACHEVice President, Aspirus Heart and Vascular Nothing to Disclose

Curt J. Daniels, MD, FACC Chairman, ACC Adult Congenital Heart Association Medical Advisory Board; Dottie Dohan Shepard Endowed Chair; Professor, Internal Medicine and Pediatrics; Director, COACH program at the Heart Center: Nationwide Children’s Hospital, The Ohio State University Medical Center, Columbus Nothing to Disclose

Kristin Doster, BS, RDCS, FASE, CPASExecutive Director, Prairie Heart Institute of Illinois Consultant Fees/Honoraria: Edwards Lifesciences

Ted Feldman, MD, MSCAI, FACC, FESCDirector, Cardiac Catheterization Laboratory Evanston Hospital, NorthShore Health SystemConsultant Fees/Honoraria: Abbott, Boston Scientific, Edwards, WL Gore; Research/Research Grants: Abbott, Boston Scientific Corporation, Edwards, WL Gore

Jorge F. Saucedo, MD, MBA, FACCAllstate Foundation, Judson B. Branch Chair of Cardiology; Chief, Division of Cardiology and Co-Director, NorthShore University Health System; Clinical Professor of Medicine, University of Chicago Pritzker School of Medicine Consultant Fees/Honoraria: Daiichi Sankyo, Eli Lilly, Janssen Pharmaceuticals, MerckOfficer/Director/Other Fiduciary Role: Vascular Solutions

Mia Stone, MS, BSN, RN, AACC, FACCASystem Director of CV Services Quality and Care Management, Aurora Health CareWI-ACC CV Team RepNothing to Disclose

Kim A. Williams, Sr., MD, FACC, FAHA, FASNCACC President; James B. Herrick Professor; Chief, Division of Cardiology, Rush University School of MedicineNothing to Disclose

Clyde W. Yancy, MD, MSc, MACC, FAHA, MACPMagerstadt Professor of Medicine and Chief, Division of Cardiology, Northwestern University, Feinberg School of Medicine; Associate Director, Bluhm Cardiovascular Institute, Northwestern Memorial HospitalDisclosure provided by Rockpointe

Program Faculty

Program Director: Firas J. Al Badarin, MD, FACC Prairie Cardiovascular ConsultantsHeart Institute of Southern IllinoisIL-ACC CouncilorNothing to Disclose

Content Representative: Cathie Biga, RN, MSN, President & CEOCardiovascular Management of Illinois (CMI)IL-ACC Administrator Representative Ownership Interest/Partnership/Principal: CMI, Aftershock; Speaker’s Bureau: MedAxiom Advisory BoardConsulting Fees, Honoraria: Cardiology Advocacy Committee

Nurse Planner: Nathalie De Michelis, RN, MSNCV Program Manager, UC Irvine Healthcare CA Nothing to Disclose

Raed Al-Dallow, MD, FACCPrairie Cardiovascular ConsultantsIL-ACC Councilor Speakers Bureau: Abbott Vascular, Janssen J&J, Trivascular

Jay Alexander, MD, FACC, FAHA, FSNCNorth Shore Cardiologists, S.C.Governor, Illinois Chapter ACCOfficer/Director/Other Fiduciary Role: iRythmn Technologies

Agnes B. Delaney, PA-CPrairie Cardiovascular ConsultantsIL-ACC CV Team RepresentativeNothing to Disclose

David L. Fishman, MD, FACCPresence Our Lady of Resurrection Medical CenterIL-ACC Councilor Nothing to Disclose

Karen L. Lambert, MD, FACCIllinois Heart and VascularIL-ACC CouncilorNothing to Disclose

Anuj Mediratta, MDUniversity of Chicago MedicineIL-ACC FIT Representative Nothing to Disclose

Roberto Pacheco-Coronado, MD, FACCPrairie Cardiovascular ConsultantsIL-ACC Councilor Nothing to Disclose

Nancy Mueller, MBAIL-ACC Chapter Executive Nothing to Disclose

Planning Committee

Faculty and Planning cOmmittee

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC), the American College of Cardiology Foundation (ACCF) must ensure balance, independence, objectivity and scientific rigor in all of their directly sponsored or jointly sponsored educational activities. Provider(s) and faculty participating in a sponsored activity are required to disclose to the audience any significant financial interests or other relationships he/she or a member of their immediate family may have (1) with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. ACCF is committed to providing its learners with high-quality activities and materials that promote improvements and quality in health care and not a specific proprietary business or commercial interest. The intent of this disclosure is not to prevent participation in sponsored educational activities by persons with a financial or other relationship, but rather to provide learners with information on which they can make their own determination whether financial interests or relationships may influence the credited activity. Any individual refusing to provide adequate disclosure consistent with this policy will be prohibited from participation in any future ACCF education activities.

ACCF assesses conflict of interest (COI) with its faculty, planners, managers, staff and other individuals who are in a position to control the content of CME/CNE-credited activities. All relevant potential conflicts of interest that are identified are thoroughly vetted through a process that includes course directors and appropriate peer review by education committee chairs/members, for fair balance, scientific objectivity and validity, and patient care and safety recommendations.

ACCF also requires that all faculty presenters disclose their intent to discuss any unlabeled/unapproved uses of drugs and/or devices during their presentations.

ACCF Disclosure/Conflict of Interest/Off-Label Statement

The American College of Cardiology Foundation (ACCF) recognizes that you are a life-long learner who has chosen to engage in continuing medical education to identify or fill a gap in knowledge or skill; and to attain or enhance a desired competency. As part of ACCF’s duty to you as a learner, you have the right to expect that your continuing medical education experience with ACCF includes the following (you will be queried at the end of the activity regarding your impressions):

LEARNER BILL OF RIGHTS

Content that:• Promotes improvements or quality in healthcare• Is current, valid, reliable, accurate and evidence-

based• Addresses the stated objectives or purpose• Is driven by and based on independent survey

and analysis of learner needs, not commercial interests

• Has been reviewed for bias and scientific rigor• Offers balanced presentations that are free of

commercial bias• Is vetted through a process that resolves any

conflicts of interest of planners and faculty• Is evaluated for its effectiveness in meeting the

identified educational need

A learning environment that:• Is based on adult learning principles that

support the use of various modalities• Supports learners’ abilities to meet their

individual needs• Respects and attends to any special needs of the

learners• Respects the diversity of groups of learners• Is free of promotional, commercial and/or sales

activities

Disclosure of: • Relevant financial relationships that planners,

teachers and authors have with commercial interests related to the content of the activity

• Commercial support (funding or in-kind resources) of this activity

Abstracts and articles contained in this program guide have been reprinted with permission.

This information is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a clinician relative to diagnostic and treatment options for a specific patient’s medical condition.

The American College of Cardiology Foundation (ACCF) does not warrant the completeness, accuracy or usefulness of any opinions, advice, services or other information provided through this activity. In no event will ACCF be liable for any decision made, or action taken, in reliance upon the information provided through this activity.

Accredited status does not imply endorsement by the ACCF of any commercial products displayed in conjunction with this activity.

ACCF reserves the right to modify faculty and program without notice.

DISCLAIMER STATEMENT

nOtices

agenda

Registration, Exhibits, and Breakfast 7:00-7:25 am

Welcome and Opening Remarks 7:25-7:30 am

PATIENT MANAGEMENT UPDATE Keynote Speaker: Update On Structural Interventions: TAVR, MitraClip and More

Ted Feldman, MD, MSCAI, FACC, FESCDirector, Cardiac Catheterization Laboratory, Evanston Hospital, NorthShore Health System

7:30-8:15 am

How To Set Up An Effective Structural Heart Clinic

Kristin Doster, BS, RDCS, FASE, CPASExecutive Director, Prairie Heart Institute of Illinois

8:15-8:45 am

Controversies in Dual Antiplatelet Therapy

Jorge F. Saucedo, MD, MBA, FACCAllstate Foundation, Judson B. Branch Chair of Cardiology; Chief, Division of Cardiology and Co-Director, NorthShore University Health System; Clinical Professor of Medicine, University of Chicago Pritzker School of Medicine

8:45-9:30 am

Adult Congenital Heart Disease Update

Curt J. Daniels, MD, FACCChairman, ACC Adult Congenital Heart Association Medical Advisory Board; Dottie Dohan Shepard Endowed Chair; Professor, Internal Medicine and Pediatrics; Director, COACH program at the Heart Center: Nationwide Children’s Hospital, The Ohio State University Medical Center, Columbus

9:30-10:15 am

Break/Exhibits 10:15-10:45 am

Current Approaches and Future Directions in the Management of Patients with Resistant Heart Failure

Clyde W. Yancy, MD, MSc, MACC, FAHA, MACPMagerstadt Professor of Medicine and Chief, Division of Cardiology, Northwestern University, Feinberg School of Medicine; Associate Director, Bluhm Cardiovascular Institute, Northwestern Memorial Hospital

10:45-11:45 am

NOTE: Additional 1.0 CME credit for this lecture is jointly provided by Potomac Center for Medical Education and Rockpointe

Break/Exhibits 11:45-12:00 pm

Lunch Advocacy Speaker - Evelyn Sanguinetti, Illinois Lt. Governor

12:00-12:45 pm

Keynote Speaker: ACC Update Kim Williams, Sr., MD, FACCFAHA, FASNCACC President; James B. Herrick Professor; Chief, Division of Cardiology, Rush University School of Medicine

12:45-1:30 pm

MINI CARDIOVASCULAR SUMMITHospital Value & Quality Programs

Mia Stone, MS, BSN, RN, AACC, FACCASystem Director of CV Services Quality and Care Management, Aurora Health Care

1:30-2:00 pm

Ambulatory Practice Value & Quality Programs

Cathleen Biga, RN, MSNPresident & CEO, Cardiovascular Management of Illinois

2:00-3:00 pm

Team Based Care Ginger Biesbrock, PA-C, MPH, MPAS, AACCVice President, Consulting, MedAxiom

3:00-3:45 pm

Governance of Your Cardiovascular Service Line

Steve Brewer, MBA, CMPE, FACHEVice President, Aspirus Heart and Vascular

3:45-4:15 pm

Friday, May 29, 20157:00 am - 4:15 pm

The Hyatt Lodge at McDonald’s Campus2815 Jorie Boulevard

Oak Brook, Illinois 60523

Hot topics in contemporary cardiovascular

practice &

il-acc annual meeting

Appreciation is expressed to the following companies for exhibiting at this symposium.

exhibitOrs

actelion pHarmaceuticals

aegerion pHarmaceuticals

amgen

arbor pHarmaceuticals, llc

astellas pHarma us, inc.

astraZeneca (Wi division)

astraZeneca (il division)

boeHringer ingelHeim pHarmaceuticals

boston scientific

bristol-myers squibb

daiicHi sankyo, inc.

eli lilly and company

genZyme

irHytHm tecHnologies

Janssen pHarmaceuticals

lantHeus medical imaging

lifeWatcH services, inc.

tHe medicines company

medicure, inc.

otsuka pHarmaceuticals

pfiZer

sanofi

scimage, inc.

spartan bioscience

tHoratec corporation

Zoll lifevest